trial · primary record
Tofacitinib
Sjogren's Syndrome
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2030-12-15 |
| Primary endpoint | Number of Adverse Events by Grade/Category |
| Registry ID | NCT07281456 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:07.844Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07281456
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.